Scarica l'app Stockscreener
12.35
3.29%
-0.42
Dopo l'orario di chiusura:
12.50
0.15
+1.21%
Oric Pharmaceuticals Inc Borsa (ORIC) Ultime notizie
Oric Pharmaceuticals director Heyman sells $86,524 in ORIC stock By Investing.com - Investing.com South Africa
Form 4 Oric Pharmaceuticals Inc: Richard A. Heyman (Director) For: 1 October - Investing.com UK
Cancer Research UK will fund early testing of a potential cancer treatment. - stocktitan.net
A director exercised options at $1.60 and sold 3,500 Oric Pharmaceuticals (ORIC) shares. - Stock Titan
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Six new hires received options to buy shares and stock awards from ORIC Pharmaceuticals - Stock Titan
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
A director proposes selling 8,100 shares of Oric Pharmaceuticals (ORIC). - Stock Titan
A proposed sale covers 7,600 Oric Pharmaceuticals (ORIC) shares held by RAHD Capital. - Stock Titan
Oric Pharma CFO sells $181k in shares By Investing.com - Investing.com South Africa
Form 4 Oric Pharmaceuticals Inc For: 29 September By Investing.com - Investing.com Nigeria
Oric Pharma CFO sells $181k in shares - Investing.com
Form 4 Oric Pharmaceuticals Inc For: 29 September - Investing.com India
Form 4 Oric Pharmaceuticals Inc For: 29 September By Investing.com - Investing.com UK
After a $4.36 option exercise, Oric Pharmaceuticals (ORIC) CFO sells 13,400 shares. - stocktitan.net
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Stock Has Average Target Price of $20.18 - MarketBeat
1,078,055 Shares of Oric Pharmaceuticals, Inc. $ORIC Purchased by Bank of America Corp DE - MarketBeat
Oric Pharmaceuticals CFO Dominic Piscitelli sells $8,102 in shares - Investing.com
Oric Pharmaceuticals CFO Dominic Piscitelli sells $8,102 in shares By Investing.com - Investing.com Canada
Form 4 Oric Pharmaceuticals Inc For: 25 September By Investing.com - Investing.com Canada
Form 4 Oric Pharmaceuticals Inc For: 25 September By Investing.com - Investing.com India
A finance chief exercised 600 options and sold 600 shares at Oric Pharmaceuticals (ORIC). - stocktitan.net
Form 4 Oric Pharmaceuticals Inc For: 25 September By Investing.com - Investing.com UK
ORIC Pharmaceuticals (Nasdaq:ORIC)Stock Analysis - Simply Wall Street
Oric Pharmaceuticals Inc (NYSE: ORIC) Share Price, ORIC Stock News, ORIC Share Price & Updates - kalkine.com.au
Squarepoint Ops LLC Purchases Shares of 344,343 Oric Pharmaceuticals, Inc. $ORIC - marketbeat.com
Precision Trading with Oric Pharmaceuticals Inc. (ORIC) Risk Zones - Stock Traders Daily
ORIC: Advancing late-stage prostate and lung cancer programs with robust funding and global trials - TradingView
ORIC: Phase III trials and robust funding position support late-stage oncology pipeline growth - TradingView
ORIC Pharmaceuticals at Wells Fargo conference: late-stage pipeline in focus - Investing.com Canada
ORIC Pharmaceuticals at Wells Fargo conference: late-stage pipeline in focus - Investing.com India
Oric Pharmaceuticals joins 2026 Cantor Global Healthcare Conference fireside chat: Can ORIC break above $12.51? - Traders Union
ORIC: Advancing late-stage cancer therapies with strong efficacy, safety, and major market potential - TradingView
Enterprise value to revenue forward of Oric Pharmaceuticals, Inc. – NASDAQ:ORIC - TradingView
Enterprise value to revenue forward of Oric Pharmaceuticals, Inc. – MUN:4TZ - TradingView
ORIC stock holds steady as biotech eyes next trial and earnings - AD HOC NEWS
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial - TipRanks
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences - Yahoo Finance
ORIC stock holds firm as biotech valuation nears 0.93 billion USD - ad-hoc-news.de
(ORIC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Oric Pharmaceuticals Inc (NYSE: ORIC) Share Price, ORIC Stock News, ORIC Share Price & Updates - kalkine.ca
Oric Pharmaceuticals stock holds above $13 as BlackRock boosts stake - ad-hoc-news.de
Oric Pharmaceuticals (NASDAQ: ORIC) CFO sells 77,000 shares - Stock Titan
Oric Pharmaceuticals Insider Sold Shares Worth $1,053,814, According to a Recent SEC Filing - Yahoo Finance
ORIC Pharmaceuticals (NASDAQ: ORIC) officer plans $3.1M stock sale - Stock Titan
Blue Owl Capital Holdings LP Invests $4.33 Million in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) Sets New 12-Month HighHere's Why - MarketBeat
Oric (ORIC) Earnings Report: EPS Misses Its Estimate in Latest Trading; After Earnings: The Stock Gains 4.04% in the Latest SessionForward EPS Estimate - vinanet.vn
2.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):